Articles
A recent study reports 36% of women quit breast cancer therapy early due to the medications’ side effects, which are more severe and widespread than previously known. Plus, the Northwestern Medicine research reveals a disparity between what women tell their physicians regarding side effects and what women actually experience.
Read More ›New research shows that breast cancer survivors may face problems with cognitive abilities several years after therapy, regardless of whether they received chemotherapy plus radiation or radiation only. The study, published early online in Cancer, indicates possible common and treatment-specific ways in which cancer treatments negatively affect cancer survivors’ cognitive skills.
Read More ›The holidays mean family, fun, and festive foods. Some foods are sweet, some foods are salty, and some holiday foods may even help fight cancer. “While these so-called holiday foods are delicious to eat, they can also have the added bonus of containing cancer-preventing nutrients,” says Stephanie Meyers, MS, RD/LDN, nutritionist at Dana-Farber Cancer Institute in Boston. The following is a list of foods and recipes that should be on your menu this holiday season.
Go Nutty
Read More ›More than one-third (34%) of women with secondary breast cancer are unnecessarily encumbered by uncontrolled pain, according to new research by Breast Cancer Care and the University of Southampton.
The study, led by the Dean of the Faculty of Health Sciences, professor Jessica Corner, was published in the Journal of Pain and Symptom Management.
Of the 235 women included in the study, researchers found:
Read More ›
A new research institute at The University of Texas MD Anderson Cancer Center is intended to create effective new cancer medications and corresponding diagnostics using fundamental discoveries and modern technologies, according to Raymond DuBois, MD, PhD, MD Anderson’s executive vice president and provost.
Read More ›Three million people in the U.S. are affected by lymphedema. Often times, it is believed that exercise induces or worsens lymphedema. However, after reviewing the literature, researchers say the exercise benefits outweigh the risks for breast cancer survivors and patients with lymphedema.
A professor in the Sinclair School of Nursing, Jane Armer, says patients at risk for lymphedema can exercise if they closely monitor their activities.
Read More ›The holiday season brings about specific pitfalls – and opportunities – for cancer survivors who desire to stay healthy throughout the season and beyond.
These tips for survivors and anyone else who wants a healthier holiday and less-stressful new year are courtesy of Karen Syrjala, Ph.D., co-director of the Fred Hutchinson Cancer Research Center Survivorship Program.
Read More ›Patients who receive chemotherapy for breast cancer may experience lingering fatigue years after their therapy, according to a follow-up study published in the American Cancer Society's recent issue of Cancer.
"Fatigue is among the most common symptoms reported by women who are treated for breast cancer," said study corresponding author Paul B. Jacobsen, Ph.D., program leader for Health Outcomes and Behavior at Moffitt.
Read More ›An independent review of the cancer research advances of 2011 was released this week by the American Society of Clinical Oncology (ASCO). The report, titled Clinical Cancer Advances 2011: ASCO’s Annual Report on Progress Against Cancer, identifies oncology trends with the most potential and provides insights from experts on the future of cancer care.
Read More ›Researchers have found that cisplatin binds 20-times more pervasively to RNA than to DNA. This makes RNA a possible new drug target for cisplatin, a compound used to fight nearly 70% of all human cancer tumors.
Although patients treated with cisplatin often experience a reduction in tumor size, use of the drug is frequently discontinued due to toxicities including anemia, gastrointestinal problems, nerve damage, renal insufficiency, and tinnitus.
Read More ›